Alembic Pharmaceuticals Limited (BOM:533573)
820.50
+6.15 (0.76%)
At close: Aug 21, 2026
Alembic Pharmaceuticals Employees
Alembic Pharmaceuticals had 17,244 employees as of March 31, 2026. The number of employees increased by 673 or 4.06% compared to the previous year.
Employees
17,244
Change (1Y)
673
Growth (1Y)
4.06%
Revenue / Employee
4.51M INR
Profits / Employee
402.15K INR
Market Cap
161.53B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 17,244 | 673 | 4.06% |
| Mar 31, 2025 | 16,571 | 1,713 | 11.53% |
| Mar 31, 2024 | 14,858 | 265 | 1.82% |
| Mar 31, 2023 | 14,593 | 2,377 | 19.46% |
| Mar 31, 2022 | 12,216 | 56 | 0.46% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Jubilant Pharmova | 5,657 |
| J. B. Chemicals & Pharmaceuticals | 5,602 |
| CORONA Remedies | 5,153 |
| Granules India | 4,306 |
| Caplin Point Laboratories | 3,966 |
| Viyash Scientific | 2,900 |
| Procter & Gamble Health | 1,326 |
| Rubicon Research | 1,290 |
Alembic Pharmaceuticals News
- 18 days ago - Alembic Pharmaceuticals Transcript: Q1 26/27 - Transcripts
- 18 days ago - Alembic Pharmaceuticals Quarterly report: Q1 2027 - Filings
- 18 days ago - Alembic Pharmaceuticals Slides: Q1 2027 - Filings
- 7 weeks ago - Pharma sector stocks today, July 2: Alembic Pharma falls 1.88%, Glenmark Pharma jumps 0.91%, Sun Pharma gains 0.67% - Business Upturn
- 7 weeks ago - Top stocks for trade today June 29: Persistent Systems, Alembic Pharma, Lupin, Adani Green, BEML and more - Business Upturn
- 2 months ago - Alembic Pharmaceuticals receives USFDA final approval for Dapsone Gel, 5% - Business Upturn
- 2 months ago - Alembic Pharmaceuticals receives USFDA approval for Oseltamivir Phosphate - Business Upturn
- 2 months ago - Alembic Pharmaceuticals receives USFDA tentative approval for Binimetinib Tablets, 45 mg - Business Upturn